IMAGE

Fig. 2

ID
ZDB-IMAGE-160505-13
Source
Figures for Tan et al., 2016
Image
Figure Caption

Fig. 2

HEXIM1 Activity Suppresses Melanoma In Vivo

(A) 19-week-old Tg(mitfa:BRAFV600E);p53-/-;mitfa-/- zebrafish are shown with rescued melanocytes expressing tumor accelerator SETDB1, background control EGFP, or HEXIM1/hexim1 in the MiniCoopR system.

(B) Tumor-free survival curves for EGFP, SETDB1, and HEXIM1/hexim1 MiniCoopR zebrafish over 25 weeks. Percentages of the total number of zebrafish that were tumor free each week are plotted.

(C) Tumor-free survival curves for MiniCoopR overexpression of human HEXIM1-4A, and HEXIM1-4D are shown.

(D) Tumor-free survival curves for MiniCoopR expression of p53 and hexim CRISPRs are shown.

(E) Tumor growth rates of individual mouse xenografts with a Tet-On HEXIM1-inducible A375 cell line (A375-HEXIM1) over 14 days. Mice were fed either a standard diet or doxycycline diet (mean of seven replicates ± SD).

See also Figure S2.

Figure Data
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Mol. Cell